fda compounding glp-1 enforcement news Crackdown FDA restricts non-approved compounded GLP-1

While TB-500 has intriguing animal data, as it stands, there are no standardized, evidence-based TB-500 dosage guidelines from large human studies

[7] A boxed warning in the US prescribing information cautions that medullary thyroid cancers have been observed in rats treated with liraglutide, but it is "unknown whether liraglutide causes thyroid C-cell tumors, including medullary thyroid carcinoma, in humans, as relevance to humans of such tumors in rodents has not been determined." [7] Thyroid cancer [edit] At exposures eight times greater than those used in humans, liraglutide caused a statistically significant increase in thyroid tumors in rats

Supports Exercise Performance

Safety and Side Effects: What Is Known and What Is Not The honest answer is that DSIP's safety profile in humans is incompletely characterized because no large, long-term controlled trial has been conducted